Bolder BioTechnology awarded $593K to research radiation exposure

Bolder BioTechnology awarded $593K to research radiation exposure

BOULDER -- Bolder BioTechnology, Inc. announced it received a two-year Small Business Innovation Research Grant totaling$593,507from the National Institute of Allergy and Infectious Diseases... Read More

Tuesday July 23, 2019 0 comments Tags: Boulder, Bolder BioTechnology, George Cox

Bolder BioTechnology announces positive results for cancer treatment drug

Bolder BioTechnology announces positive results for cancer treatment drug

BOULDER -- Bolder BioTechnology, Inc. announced it has completed a Phase 1 clinical trial of BBT-015, a proprietary long-acting granulocyte colony-stimulating factor (G-CSF) analog, in healthy... Read More

Tuesday May 1, 2018 0 comments Tags: Boulder, Bolder BioTechnology, BBT-015, Joe Cox